Post by Artivion, Inc.
44,971 followers
Artivion is proud to announce that the FDA has approved the premarket approval application (PMA) for the AMDS™ Hybrid Prosthesis. "This approval, following our recent acquisition of the PMA-approved NEXUS system and continued clinical trial enrollment progress for ARCEVO LSA, marks another step forward in our vision of Artivion as the only company globally with a complete portfolio of market leading aortic arch solutions”, said Pat Mackin, Chairman, President and CEO. This achievement is an important milestone in advancing treatment options for aortic disease. For more details, access the press release here: https://lnkd.in/e6WZuWfK
Video Content